UK markets closed

Amicus Therapeutics, Inc. (FOLD)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
10.22-0.32 (-3.08%)
As of 01:44PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
399,356
399,356
329,233
305,514
260,886
Cost of revenue
37,326
37,326
38,599
34,466
31,044
Gross profit
362,030
362,030
290,634
271,048
229,842
Operating expenses
Research development
152,381
152,381
276,677
272,049
308,443
Selling general and administrative
275,270
275,270
213,041
192,710
156,407
Total operating expenses
435,524
435,524
495,060
470,968
473,696
Operating income or loss
-73,494
-73,494
-204,426
-199,920
-243,854
Interest expense
50,149
50,149
37,119
32,471
22,425
Total other income/expenses net
-33,536
-33,536
-3,518
-9,672
-11,201
Income before tax
-150,101
-150,101
-242,039
-241,554
-274,254
Income tax expense
1,483
1,483
-5,471
8,906
2,598
Income from continuing operations
-151,584
-151,584
-236,568
-250,460
-276,852
Net income
-151,584
-151,584
-236,568
-250,460
-276,852
Net income available to common shareholders
-151,584
-151,584
-236,568
-250,460
-276,852
Basic EPS
-0.59
-
-0.82
-0.92
-1.07
Diluted EPS
-0.59
-
-0.82
-0.92
-1.07
Basic average shares
292,412
-
289,057
271,422
258,867
Diluted average shares
292,412
-
289,057
271,422
258,867